HRSA Releases Notice About 340B Program Rebate Model
In 2025, the Health Resources and Services Administration opened a 340B Drug Pricing Program rebate model to certain manufacturers who volunteered as participants. HRSA later paused implementation due to litigation. HRSA now has released a notice that advances a 340B program rebate model to begin Jan. 1, 2027. Manufacturers who would like to participate in the model must apply by Monday, Aug. 24.
The new model will require 340B providers to send a claim to participating manufacturers for purchases of 340B drugs included as selected pilot program drugs. Then the manufacturer will issue rebates to the 340B provider. When a claim is filed, manufacturers will not be permitted to deny a rebate based on suspected instances of diversion, duplicate discounts between 340B and Medicaid, eligible issues with the provider or insufficient purchases of a drug at full price. Such issues remain subject to agency review, manufacturer audits and 340B Administrative Dispute Resolution processes.
The Missouri Hospital Association is a nonprofit association in Jefferson City that represents 136 Missouri hospitals. In addition to representation and advocacy on behalf of its membership, the association offers continuing education programs on current health care topics and seeks to educate the public about health care issues.